Karen Marchillo

4.3k total citations
52 papers, 3.4k citations indexed

About

Karen Marchillo is a scholar working on Infectious Diseases, Pharmacology and Molecular Medicine. According to data from OpenAlex, Karen Marchillo has authored 52 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Infectious Diseases, 32 papers in Pharmacology and 18 papers in Molecular Medicine. Recurrent topics in Karen Marchillo's work include Antifungal resistance and susceptibility (36 papers), Antibiotics Pharmacokinetics and Efficacy (28 papers) and Antibiotic Resistance in Bacteria (18 papers). Karen Marchillo is often cited by papers focused on Antifungal resistance and susceptibility (36 papers), Antibiotics Pharmacokinetics and Efficacy (28 papers) and Antibiotic Resistance in Bacteria (18 papers). Karen Marchillo collaborates with scholars based in United States, France and Germany. Karen Marchillo's co-authors include David R. Andes, Jeniel E. Nett, Alexander J. Lepak, R. Conklin, Jamie VanHecker, Daniel J. Diekema, Michael A. Pfaller, Ralph M. Albrecht, Miao Zhao and Kyler Crawford and has published in prestigious journals such as The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy and Infection and Immunity.

In The Last Decade

Karen Marchillo

52 papers receiving 3.3k citations

Peers

Karen Marchillo

EPIDE

PHARM

Francesco Barchiesi Italy

Javier Pemán Spain

Priya Uppuluri United States

Elizabeth L. Berkow United States

William R. Kirkpatrick United States

Frédéric Lamoth Switzerland

Hsiu‐Jung Lo Taiwan

P. David Rogers United States

Ranjith Rajendran United Kingdom

Alix T. Coste Switzerland

Francesco Barchiesi Italy

Karen Marchillo

3.7k ×1.4

3.0k ×1.9

EPIDE

456 ×0.5

PHARM

900 ×1.1

327 ×1.2

Citations per year, relative to Karen Marchillo Karen Marchillo (= 1×) peers Francesco Barchiesi

Countries citing papers authored by Karen Marchillo

Since Specialization

Citations

This map shows the geographic impact of Karen Marchillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Marchillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Marchillo more than expected).

Fields of papers citing papers by Karen Marchillo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Marchillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Marchillo. The network helps show where Karen Marchillo may publish in the future.

Co-authorship network of co-authors of Karen Marchillo

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Marchillo. A scholar is included among the top collaborators of Karen Marchillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Marchillo. Karen Marchillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Miao, Alexander J. Lepak, Karen Marchillo, & David R. Andes. (2019). In Vivo Pharmacodynamic Target Determination for Delafloxacin against Klebsiella pneumoniae and Pseudomonas aeruginosa in the Neutropenic Murine Pneumonia Model. Antimicrobial Agents and Chemotherapy. 63(10). 11 indexed citations

Zhao, Miao, Alexander J. Lepak, Karen Marchillo, et al.. (2019). APX001 Pharmacokinetic/Pharmacodynamic Target Determination against Aspergillus fumigatus in an In Vivo Model of Invasive Pulmonary Aspergillosis. Antimicrobial Agents and Chemotherapy. 63(4). 34 indexed citations

Lepak, Alexander J., Miao Zhao, Karen Marchillo, Jamie VanHecker, & David R. Andes. (2019). In Vivo Pharmacodynamic Evaluation of Omadacycline against Staphylococcus aureus in the Neutropenic Mouse Pneumonia Model. Antimicrobial Agents and Chemotherapy. 64(2). 11 indexed citations

Zhao, Miao, Alexander J. Lepak, Brian VanScoy, et al.. (2018). In Vivo Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse Model. Antimicrobial Agents and Chemotherapy. 62(4). 54 indexed citations

Nett, Jeniel E., et al.. (2016). Targeting Fibronectin To Disrupt In Vivo Candida albicans Biofilms. Antimicrobial Agents and Chemotherapy. 60(5). 3152–3155. 19 indexed citations

Davis, Stephen, Benjamin Vincent, Matthew M. Endo, et al.. (2015). Nontoxic antimicrobials that evade drug resistance. Nature Chemical Biology. 11(7). 481–487. 73 indexed citations

Davis, Stephen, Benjamin Vincent, Matthew M. Endo, et al.. (2015). Nontoxic antimicrobials that evade drug resistance. DSpace@MIT (Massachusetts Institute of Technology). 1 indexed citations

Lepak, Alexander J., Karen Marchillo, Jamie VanHecker, Nkechi Azie, & David R. Andes. (2015). Efficacy of Extended-Interval Dosing of Micafungin Evaluated Using a Pharmacokinetic/Pharmacodynamic Study with Humanized Doses in Mice. Antimicrobial Agents and Chemotherapy. 60(1). 674–677. 8 indexed citations

Lepak, Alexander, et al.. (2014). Impact of MIC Range for Pseudomonas aeruginosa and Streptococcus pneumoniae on the Ceftolozane In Vivo Pharmacokinetic/Pharmacodynamic Target. Antimicrobial Agents and Chemotherapy. 58(10). 6311–6314. 48 indexed citations

10.

Lepak, Alexander J., Karen Marchillo, & David R. Andes. (2014). Pharmacodynamic Target Evaluation of a Novel Oral Glucan Synthase Inhibitor, SCY-078 (MK-3118), Using an In Vivo Murine Invasive Candidiasis Model. Antimicrobial Agents and Chemotherapy. 59(2). 1265–1272. 79 indexed citations

11.

Taff, Heather, Karen Marchillo, & David R. Andes. (2013). Preparation of Candida albicans Biofilms Using an in vivo Rat Central Venous Catheter Model. BIO-PROTOCOL. 3(14). 2 indexed citations

12.

Zhang, Jianjun, Larissa V. Ponomareva, Karen Marchillo, et al.. (2013). Synthesis and Antibacterial Activity of Doxycycline Neoglycosides. Journal of Natural Products. 76(9). 1627–1636. 14 indexed citations

13.

Peltier‐Pain, Pauline, Karen Marchillo, Maoquan Zhou, David R. Andes, & Jon S. Thorson. (2012). Natural Product Disaccharide Engineering through Tandem Glycosyltransferase Catalysis Reversibility and Neoglycosylation. Organic Letters. 14(19). 5086–5089. 35 indexed citations

14.

Nett, Jeniel E., Karen Marchillo, & David R. Andes. (2012). Modeling of Fungal Biofilms Using a Rat Central Vein Catheter. Methods in molecular biology. 845. 547–556. 15 indexed citations

15.

Nett, Jeniel E., Alexander J. Lepak, Karen Marchillo, & David R. Andes. (2009). Time Course Global Gene Expression Analysis of an In VivoCandidaBiofilm. The Journal of Infectious Diseases. 200(2). 307–313. 135 indexed citations

16.

Nett, Jeniel E., et al.. (2007). β‐1,3 Glucan as a Test for Central Venous Catheter Biofilm Infection. The Journal of Infectious Diseases. 195(11). 1705–1712. 70 indexed citations

17.

Andes, David R., Daniel J. Diekema, Michael A. Pfaller, et al.. (2007). In Vivo Pharmacodynamic Characterization of Anidulafungin in a Neutropenic Murine Candidiasis Model. Antimicrobial Agents and Chemotherapy. 52(2). 539–550. 111 indexed citations

18.

Andes, David R., Alexander J. Lepak, Jeniel E. Nett, Lynette Lincoln, & Karen Marchillo. (2006). In Vivo Fluconazole Pharmacodynamics and Resistance Development in a Previously SusceptibleCandida albicansPopulation Examined by Microbiologic and Transcriptional Profiling. Antimicrobial Agents and Chemotherapy. 50(7). 2384–2394. 27 indexed citations

19.

Andes, David R., et al.. (2005). A Simple Approach for Estimating Gene Expression inCandida albicansDirectly from a Systemic Infection Site. The Journal of Infectious Diseases. 192(5). 893–900. 43 indexed citations

20.

Andes, David R., et al.. (2003). In Vivo Pharmacodynamics of a New Triazole, Ravuconazole, in a Murine Candidiasis Model. Antimicrobial Agents and Chemotherapy. 47(4). 1193–1199. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact